These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 37407538)

  • 1. [Research Progress of microRNA-7/124/155 in Parkinson's Disease].
    Chen T; Chen H; Yan WH; Zhu MY
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2023 Jun; 45(3):484-492. PubMed ID: 37407538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dysregulated microRNAs in neural system: Implication in pathogenesis and biomarker development in Parkinson's disease.
    Lu J; Xu Y; Quan Z; Chen Z; Sun Z; Qing H
    Neuroscience; 2017 Dec; 365():70-82. PubMed ID: 28964753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered microRNA profiles in cerebrospinal fluid exosome in Parkinson disease and Alzheimer disease.
    Gui Y; Liu H; Zhang L; Lv W; Hu X
    Oncotarget; 2015 Nov; 6(35):37043-53. PubMed ID: 26497684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Roles of Non-Coding RNAs as Novel Diagnostic Biomarkers in Parkinson's Disease.
    Manna I; Quattrone A; De Benedittis S; Iaccino E; Quattrone A
    J Parkinsons Dis; 2021; 11(4):1475-1489. PubMed ID: 34334422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of Long Non-coding RNAs in the Pathogenesis of Alzheimer's and Parkinson's Diseases.
    Sivagurunathan N; Ambatt ATS; Calivarathan L
    Curr Aging Sci; 2022; 15(2):84-96. PubMed ID: 35081899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of microRNA-485 in neurodegenerative diseases.
    Ryu IS; Kim DH; Cho HJ; Ryu JH
    Rev Neurosci; 2023 Jan; 34(1):49-62. PubMed ID: 35793556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Understanding the Involvement of microRNAs in Mitochondrial Dysfunction and Their Role as Potential Biomarkers and Therapeutic Targets in Parkinson's Disease.
    Tryphena KP; Anuradha U; Kumar R; Rajan S; Srivastava S; Singh SB; Khatri DK
    J Alzheimers Dis; 2023; 94(s1):S187-S202. PubMed ID: 35848027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of plasma microRNA expression changes in multiple system atrophy and Parkinson's disease.
    Uwatoko H; Hama Y; Iwata IT; Shirai S; Matsushima M; Yabe I; Utsumi J; Sasaki H
    Mol Brain; 2019 May; 12(1):49. PubMed ID: 31088501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of miRNA on epigenetics landscape of Parkinson's disease: From pathogenesis to therapeutics.
    Uppala SN; Tryphena KP; Naren P; Srivastava S; Singh SB; Khatri DK
    Mech Ageing Dev; 2023 Jul; 213():111826. PubMed ID: 37268278
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNAs, Parkinson's Disease, and Diabetes Mellitus.
    Wang H
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33799467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Common microRNA regulated pathways in Alzheimer's and Parkinson's disease.
    Awuson-David B; Williams AC; Wright B; Hill LJ; Di Pietro V
    Front Neurosci; 2023; 17():1228927. PubMed ID: 37719162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modified level of miR-376a is associated with Parkinson's disease.
    Baghi M; Rostamian Delavar M; Yadegari E; Peymani M; Pozo D; Hossein Nasr-Esfahani M; Ghaedi K
    J Cell Mol Med; 2020 Feb; 24(4):2622-2634. PubMed ID: 31930701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recent Advances in the Roles of MicroRNA and MicroRNA-Based Diagnosis in Neurodegenerative Diseases.
    Zhang J; Chen Z; Chen H; Deng Y; Li S; Jin L
    Biosensors (Basel); 2022 Nov; 12(12):. PubMed ID: 36551041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Impact of Dysregulated microRNA Biogenesis Machinery and microRNA Sorting on Neurodegenerative Diseases.
    Weng YT; Chang YM; Chern Y
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating MicroRNAs and Long Non-coding RNAs as Potential Diagnostic Biomarkers for Parkinson's Disease.
    Yang Y; Li Y; Yang H; Guo J; Li N
    Front Mol Neurosci; 2021; 14():631553. PubMed ID: 33762908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific Signatures of Serum miRNAs as Potential Biomarkers to Discriminate Clinically Similar Neurodegenerative and Vascular-Related Diseases.
    Barbagallo C; Mostile G; Baglieri G; Giunta F; Luca A; Raciti L; Zappia M; Purrello M; Ragusa M; Nicoletti A
    Cell Mol Neurobiol; 2020 May; 40(4):531-546. PubMed ID: 31691877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tiny But Mighty: Promising Roles of MicroRNAs in the Diagnosis and Treatment of Parkinson's Disease.
    Wang Y; Yang Z; Le W
    Neurosci Bull; 2017 Oct; 33(5):543-551. PubMed ID: 28762215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma levels of miR-137 and miR-124 are associated with Parkinson's disease but not with Parkinson's disease with depression.
    Li N; Pan X; Zhang J; Ma A; Yang S; Ma J; Xie A
    Neurol Sci; 2017 May; 38(5):761-767. PubMed ID: 28181066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA machinery in Parkinson's disease: a platform for neurodegenerative diseases.
    Saghazadeh A; Rezaei N
    Expert Rev Neurother; 2022 Jun; 22(6):427-453. PubMed ID: 26574782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered Expression Levels of MicroRNA-132 and Nurr1 in Peripheral Blood of Parkinson's Disease: Potential Disease Biomarkers.
    Yang Z; Li T; Li S; Wei M; Qi H; Shen B; Chang RC; Le W; Piao F
    ACS Chem Neurosci; 2019 May; 10(5):2243-2249. PubMed ID: 30817108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.